Table 1 Clinical characteristics of patients included in the analysis \((n=43)\)
From: Surface EMG-based quantification of inspiratory effort: a quantitative comparison with Pes
Characteristic | Result |
|---|---|
Age, \(\hbox {mean} \pm \hbox {SD}\) year | \({64\pm 11}\) |
Men, \(\textit{n}\) (%) | 34 (79) |
Weight, \(\hbox {mean} \pm \hbox {SD}\) \(\hbox {kg}\) | \({79.0\pm 8.9}\) |
BMI, \(\hbox {mean} \pm \hbox {SD}\) \(\hbox {kg}\,\hbox {m}^{-2}\) | \({26\pm 6}\) |
TLC, \(\hbox {mean} \pm \hbox {SD}\) l | \({6.7\pm 2.4}\) |
VC, \(\hbox {mean} \pm \hbox {SD}\) l | \({3.6\pm 1.4}\) |
FEV1 % predicted, \(\hbox {mean} \pm \hbox {SD}\) % | \({82\pm 29}\) |
Tiffeneau index, \(\hbox {mean} \pm \hbox {SD}\) % | \({69\pm 19}\) |
RV, \(\hbox {mean} \pm \hbox {SD}\) l | \({3.4\pm 2.4}\) |
RV/TLC, \(\hbox {mean} \pm \hbox {SD}\) % | \({45\pm 19}\) |
iPEEP, \(\hbox {mean} \pm \hbox {SD}\) \({\hbox {cm}\hbox {H}_{2}\hbox {O}}\) | \({2.1\pm 1.4}\) |
Diagnosis, \(\textit{n}\) (%) | |
OSAS | 4 (9) |
COPD | 16 (37) |
GOLD I | 2 (5) |
GOLD II–III | 14 (33) |
ACOS | 3 (7) |
Bronchial asthma | 5 (19) |
ILD | 7 (17) |
Lung cancer | 20 (47) |
Infectious or rheumatic diseases | 11 (26) |